FDA Approved: CYANOCOBALAMIN — Supplemental Application (Somerset Therapeutics, LLC)

View source ↗

Summary

The FDA approved a supplemental application for cyanocobalamin from Somerset Therapeutics, LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Megaloblastic Anemia Due to Vitamin B12 Deficiency
• Pernicious Anemia
• Vitamin B12 Deficiency

Drugs mentioned

• CYANOCOBALAMIN (cyanocobalamin)

Snippet

SUPPL AP for CYANOCOBALAMIN (CYANOCOBALAMIN)